4.7 Review

Inflammation and plaque vulnerability

Journal

JOURNAL OF INTERNAL MEDICINE
Volume 278, Issue 5, Pages 483-493

Publisher

WILEY
DOI: 10.1111/joim.12406

Keywords

atherosclerosis; atherothrombosis; en-dothelial erosion; inflammation; plaque rupture

Funding

  1. Swedish Research Council [6816, 8703]
  2. Swedish Heart-Lung Foundation
  3. Stockholm County Council
  4. Foundation for Strategic Research
  5. European Commission
  6. US National Institutes of Health [R01 HL080472]
  7. National Institutes of Health (NIH) [HL107497, HL075662]
  8. National Institutes of Health (Program of Excellence in Nanotechnology (PEN) Award) [HHSN268201000045C]

Ask authors/readers for more resources

Atherosclerosis is a maladaptive, nonresolving chronic inflammatory disease that occurs at sites of blood flow disturbance. The disease usually remains silent until a breakdown of integrity at the arterial surface triggers the formation of a thrombus. By occluding the lumen, the thrombus or emboli detaching from it elicits ischaemic symptoms that may be life-threatening. Two types of surface damage can cause atherothrombosis: plaque rupture and endothelial erosion. Plaque rupture is thought to be caused by loss of mechanical stability, often due to reduced tensile strength of the collagen cap surrounding the plaque. Therefore, plaques with reduced collagen content are thought to be more vulnerable than those with a thick collagen cap. Endothelial erosion, on the other hand, may occur after injurious insults to the endothelium instigated by metabolic disturbance or immune insults. This review discusses the molecular mechanisms involved in plaque vulnerability and the development of atherothrombosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available